← Leaderboards
Bodour Salhia
University Of Southern California
$4,072,298
Attributed
$4,072,298
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,072,298 · 5
By mechanism
R01$1,920,131 · 1
U2C$1,489,279 · 1
S15$341,529 · 1
U54$244,371 · 1
P30$76,988 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Caryn Lerman$95,133,528
- Mariana C Stern$2,406,912
- W Martin Kast$9,478,408
- Anthony Boutros El-Khoueiry$6,814,457
- Heather L Wipfli$4,530,254
Others in their field
Other Emerging Leaders on “Tumor”
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$105,180,681
- Leonard Freedmand · Leidos Biomedical Research, Inc.$78,762,245
- Connie Suders · Leidos Biomedical Research, Inc.$67,882,919
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Research focus
TumorSamplingMalignant NeoplasmsLeadResidual StateSerumTumor TissueTissuesFuturePlasmaPilot ProjectsRelapsePredictive MarkerPublishingReportingNext Generation SequencingMalignant Breast NeoplasmLiquid SubstanceBiological MarkersGenesMethylationNeoplasm MetastasisGenomicsDna Methylation
Grant awards (11)
Genome Characterization Unit$1,489,279
U2C · FY2025 · CA · contact PI
KGP Hamilton NGS STAR$341,529
S15 · FY2025 · OD · contact PI
Tissue Modeling and Drug Development Core (TMDDC) Shared Resource$90,389
U54 · FY2025 · CA · contact PI
Genomic and Epigenomic Regulation$76,988
P30 · FY2025 · CA · contact PI
Tissue Modeling Core$57,218
U54 · FY2024 · CA · contact PI
Tissue Modeling Core$96,764
U54 · FY2023 · CA · contact PI
Circulating DNA methylation biomarkers in micrometastatic breast cancer$380,678
R01 · FY2021 · CA · contact PI
Circulating DNA methylation biomarkers in micrometastatic breast cancer$380,584
R01 · FY2020 · CA · contact PI
Circulating DNA methylation biomarkers in micrometastatic breast cancer$368,782
R01 · FY2019 · CA · contact PI
Circulating DNA methylation biomarkers in micrometastatic breast cancer$380,197
R01 · FY2018 · CA · contact PI
Circulating DNA methylation biomarkers in micrometastatic breast cancer$409,890
R01 · FY2017 · CA · contact PI